TMEM70 Is an Assembly Factor of Mitochondrial Complexes I and V
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Amplification of 8Q21 in Breast Cancer Is Independent of MYC and Associated with Poor Patient Outcome
Modern Pathology (2010) 23, 603–610 & 2010 USCAP, Inc. All rights reserved 0893-3952/10 $32.00 603 Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome Matthias Choschzick1, Paula Lassen1, Annette Lebeau1, Andreas Holger Marx1, Luigi Terracciano2, Uwe Heilenko¨tter3, Fritz Jaenicke4, Carsten Bokemeyer5, Jakob Izbicki6, Guido Sauter1 and Ronald Simon1 1Institute of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; 2Institute of Pathology, University Hospital Basel, Basel, Switzerland; 3Department of Gynaecology, Hospital Itzehoe, Itzehoe, Germany; 4Department of Gynaecology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; 5Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Hospital Hamburg-Eppendorf, Hamburg, Germany and 6Department of Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany Copy number gains involving the long arm of chromosome 8, including high-level amplifications at 8q21 and 8q24, have been frequently reported in breast cancer. Although the role of the MYC gene as the driver of the 8q24 amplicon is well established, the significance of the 8q21 amplicon is less clear. The breast cancer cell line SK-BR-3 contains three separate 8q21 amplicons, the distal two of which correspond to putative target genes TPD52 and WWP1. To understand the effect of proximal 8q21 amplification on breast cancer phenotype and patient prognosis, we analyzed 8q21 copy number changes using fluorescence in situ hybridization (FISH) in a tissue microarray containing more than 2000 breast cancers. Amplification at 8q21 was found in 3% of tumors, and was associated with medullary type (Po0.03), high tumor grade (Po0.0001), high Ki67 labeling index (Po0.05), amplification of MYC (Po0.0001), HER2, MDM2, and CCND1 (Po0.05 each), as well as the total number of gene amplifications (Po0.0001). -
Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10. -
Molecular Mechanism of ACAD9 in Mitochondrial Respiratory Complex 1 Assembly
bioRxiv preprint doi: https://doi.org/10.1101/2021.01.07.425795; this version posted January 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Molecular mechanism of ACAD9 in mitochondrial respiratory complex 1 assembly Chuanwu Xia1, Baoying Lou1, Zhuji Fu1, Al-Walid Mohsen2, Jerry Vockley2, and Jung-Ja P. Kim1 1Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, USA 2Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA Abstract ACAD9 belongs to the acyl-CoA dehydrogenase family, which catalyzes the α-β dehydrogenation of fatty acyl-CoA thioesters. Thus, it is involved in fatty acid β-oxidation (FAO). However, it is now known that the primary function of ACAD9 is as an essential chaperone for mitochondrial respiratory complex 1 assembly. ACAD9 interacts with ECSIT and NDUFAF1, forming the mitochondrial complex 1 assembly (MCIA) complex. Although the role of MCIA in the complex 1 assembly pathway is well studied, little is known about the molecular mechanism of the interactions among these three assembly factors. Our current studies reveal that when ECSIT interacts with ACAD9, the flavoenzyme loses the FAD cofactor and consequently loses its FAO activity, demonstrating that the two roles of ACAD9 are not compatible. ACAD9 binds to the carboxy-terminal half (C-ECSIT), and NDUFAF1 binds to the amino-terminal half of ECSIT. Although the binary complex of ACAD9 with ECSIT or with C-ECSIT is unstable and aggregates easily, the ternary complex of ACAD9-ECSIT-NDUFAF1 (i.e., the MCIA complex) is soluble and extremely stable. -
Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach
Mafalda Rita Avó Bacalhau Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach Tese de doutoramento do Programa de Doutoramento em Ciências da Saúde, ramo de Ciências Biomédicas, orientada pela Professora Doutora Maria Manuela Monteiro Grazina e co-orientada pelo Professor Doutor Henrique Manuel Paixão dos Santos Girão e pela Professora Doutora Lee-Jun C. Wong e apresentada à Faculdade de Medicina da Universidade de Coimbra Julho 2017 Faculty of Medicine Establishing the pathogenicity of novel mitochondrial DNA sequence variations: a cell and molecular biology approach Mafalda Rita Avó Bacalhau Tese de doutoramento do programa em Ciências da Saúde, ramo de Ciências Biomédicas, realizada sob a orientação científica da Professora Doutora Maria Manuela Monteiro Grazina; e co-orientação do Professor Doutor Henrique Manuel Paixão dos Santos Girão e da Professora Doutora Lee-Jun C. Wong, apresentada à Faculdade de Medicina da Universidade de Coimbra. Julho, 2017 Copyright© Mafalda Bacalhau e Manuela Grazina, 2017 Esta cópia da tese é fornecida na condição de que quem a consulta reconhece que os direitos de autor são pertença do autor da tese e do orientador científico e que nenhuma citação ou informação obtida a partir dela pode ser publicada sem a referência apropriada e autorização. This copy of the thesis has been supplied on the condition that anyone who consults it recognizes that its copyright belongs to its author and scientific supervisor and that no quotation from the -
Tomo-Seq Identifies SOX9 As a Key Regulator of Cardiac Fibrosis During Ischemic Injury
myocardial myocardial Eva van ◼ osis fibr SOX9 transcription ◼ PhD* PhD PhD PhD MSc, PhD naarden, MSc, PhD naarden, PhD* ventricular remodeling Correspondence to: Correspondence Rooij, MSc, PhD, Hubrecht Department of Institute, KNAW University Medical Cardiology, Uppsalalaan 8, Center Utrecht, The Netherlands. 3584CT Utrecht, E-mail [email protected] of Funding, see page 1408 Sources Key Words: ischemia ◼ © 2017 American Heart Association, Inc. *Drs. Lacraz and Junker contributed equally. Grégory P.A. Lacraz, MSc, P.A. Grégory MSc, Jan Philipp Junker, Monika M. Gladka, MSc, MSc Bas Molenaar, Scholman, MSc Koen T. MSc Marta Vigil-Garcia, BS Danielle Versteeg, BS Hesther de Ruiter, MSc, Vermunt, Marit W. MSc, Creyghton, Menno P. Manon M.H. Huibers, Nicolaas de Jonge, MD Alexander van Oude- Eva van Rooij, MSc, PhD 2017;136:1396–1409. DOI: 10.1161/CIRCULATIONAHA.117.027832 DOI: 2017;136:1396–1409. Circulation. blunted the cardiac fibrotic fibrotic blunted the cardiac Sox9 ). Subsequent correlation analysis allowed). Subsequent correlation Serca2 Editorial, see p 1410 , and Nppa Based on the exact local expression cues, tomo-seq can Based on the exact local expression Cardiac ischemic injury induces a pathological remodeling ischemic injury induces a pathological remodeling Cardiac , Although genome-wide transcriptome analysis on diseased tissues Tracing transcriptional differences with a high spatial resolution with a high spatial resolution transcriptional differences Tracing Col1a2 October 10, 2017 October 10, 1396 CONCLUSIONS: novel genes and key transcription factors involved in specific serve to reveal able to unveil the Using tomo-seq, we were remodeling. aspects of cardiac pointing fibrosis, of cardiac of SOX9 as a key regulator unknown relevance fibrosis. -
Human Diseases Associated with Defects in Assembly of OXPHOS Complexes
Essays in Biochemistry (2018) 62 271–286 https://doi.org/10.1042/EBC20170099 Review Article Human diseases associated with defects in assembly of OXPHOS complexes Daniele Ghezzi1,2 and Massimo Zeviani3 1Molecular Neurogenetics, Foundation IRCCS Neurological Institute Besta, Milan, Italy; 2Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; 3Medical Research Council – Mitochondrial Biology Unit, University of Cambridge, Cambridge, U.K. Correspondence: Massimo Zeviani ([email protected]) The structural biogenesis and functional proficiency of the multiheteromeric complexes forming the mitochondrial oxidative phosphorylation system (OXPHOS) require the con- certed action of a number of chaperones and other assembly factors, most of which are specific for each complex. Mutations in a large number of these assembly factors arere- sponsible for mitochondrial disorders, in most cases of infantile onset, typically character- ized by biochemical defects of single specific complexes. In fact, pathogenic mutations in complex-specific assembly factors outnumber, in many cases, the repertoire of mutations found in structural subunits of specific complexes. The identification of patients with spe- cific defects in assembly factors has provided an important contribution to the nosological characterization of mitochondrial disorders, and has also been a crucial means to identify a huge number of these proteins in humans, which play an essential role in mitochondrial bioenergetics. The wide use of next generation sequencing (NGS) has led to and will allow the identifcation of additional components of the assembly machinery of individual com- plexes, mutations of which are responsible for human disorders. The functional studies on patients’ specimens, together with the creation and characterization of in vivo models, are fundamental to better understand the mechanisms of each of them. -
High-Throughput, Pooled Sequencing Identifies Mutations in NUBPL And
ARTICLES High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency Sarah E Calvo1–3,10, Elena J Tucker4,5,10, Alison G Compton4,10, Denise M Kirby4, Gabriel Crawford3, Noel P Burtt3, Manuel Rivas1,3, Candace Guiducci3, Damien L Bruno4, Olga A Goldberger1,2, Michelle C Redman3, Esko Wiltshire6,7, Callum J Wilson8, David Altshuler1,3,9, Stacey B Gabriel3, Mark J Daly1,3, David R Thorburn4,5 & Vamsi K Mootha1–3 Discovering the molecular basis of mitochondrial respiratory chain disease is challenging given the large number of both mitochondrial and nuclear genes that are involved. We report a strategy of focused candidate gene prediction, high-throughput sequencing and experimental validation to uncover the molecular basis of mitochondrial complex I disorders. We created seven pools of DNA from a cohort of 103 cases and 42 healthy controls and then performed deep sequencing of 103 candidate genes to identify 151 rare variants that were predicted to affect protein function. We established genetic diagnoses in 13 of 60 previously unsolved cases using confirmatory experiments, including cDNA complementation to show that mutations in NUBPL and FOXRED1 can cause complex I deficiency. Our study illustrates how large-scale sequencing, coupled with functional prediction and experimental validation, can be used to identify causal mutations in individual cases. Complex I of the mitochondrial respiratory chain is a large ~1-MDa assembly factors are probably required, as suggested by the 20 factors macromolecular machine composed of 45 protein subunits encoded necessary for assembly of the smaller complex IV9 and by cohort by both the nuclear and mitochondrial (mtDNA) genomes. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Assembly Factors for the Membrane Arm of Human Complex I
Assembly factors for the membrane arm of human complex I Byron Andrews, Joe Carroll, Shujing Ding, Ian M. Fearnley, and John E. Walker1 Medical Research Council Mitochondrial Biology Unit, Cambridge CB2 0XY, United Kingdom Contributed by John E. Walker, October 14, 2013 (sent for review September 12, 2013) Mitochondrial respiratory complex I is a product of both the nuclear subunits in a fungal enzyme from Yarrowia lipolytica seem to be and mitochondrial genomes. The integration of seven subunits distributed similarly (12, 13). encoded in mitochondrial DNA into the inner membrane, their asso- The assembly of mitochondrial complex I involves building the ciation with 14 nuclear-encoded membrane subunits, the construc- 44 subunits emanating from two genomes into the two domains of tion of the extrinsic arm from 23 additional nuclear-encoded the complex. The enzyme is put together from preassembled sub- proteins, iron–sulfur clusters, and flavin mononucleotide cofactor complexes, and their subunit compositions have been characterized require the participation of assembly factors. Some are intrinsic to partially (14, 15). Extrinsic assembly factors of unknown function the complex, whereas others participate transiently. The suppres- become associated with subcomplexes that accumulate when as- sion of the expression of the NDUFA11 subunit of complex I dis- sembly and the activity of complex I are impaired by pathogenic rupted the assembly of the complex, and subcomplexes with mutations. Some assembly factor mutations also impair its activ- masses of 550 and 815 kDa accumulated. Eight of the known ex- ity (16). Other pathogenic mutations are found in all of the core trinsic assembly factors plus a hydrophobic protein, C3orf1, were subunits, and in 10 supernumerary subunits (NDUFA1, NDUFA2, associated with the subcomplexes. -
FOXRED1 (D-4): Sc-377010
SANTA CRUZ BIOTECHNOLOGY, INC. FOXRED1 (D-4): sc-377010 BACKGROUND APPLICATIONS FOXRED1 (FAD-dependent oxidoreductase domain-containing protein 1), also FOXRED1 (D-4) is recommended for detection of FOXRED1 of human origin known as FP634, is a 486 amino acid single-pass membrane protein. Utilizing by Western Blotting (starting dilution 1:100, dilution range 1:100-1:1000), FAD as a cofactor, FOXRED1 may act as a chaperone protein essential for the immunoprecipitation [1-2 µg per 100-500 µg of total protein (1 ml of cell function of mitochondrial complex I. Mutations to FOXRED1 may result in lysate)], immunofluorescence (starting dilution 1:50, dilution range 1:50- mitochondrial complex I deficiency (MT-C1D), which results in a wide range 1:500), immunohistochemistry (including paraffin-embedded sections) of clinical maladies from lethal neonatal disease to adult onset neurodegen- (starting dilution 1:50, dilution range 1:50-1:500) and solid phase ELISA erative disorders. Common phenotypes of MT-C1D include cardiomyopathy, (starting dilution 1:30, dilution range 1:30-1:3000). liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some Suitable for use as control antibody for FOXRED1 siRNA (h): sc-96988, forms of Parkinson disease. FOXRED1 exists as three alternatively spliced FOXRED1 shRNA Plasmid (h): sc-96988-SH and FOXRED1 shRNA (h) isoforms and is encoded by a gene mapping to human chromosome 11q24.2. Lentiviral Particles: sc-96988-V. With approximately 135 million base pairs and 1,400 genes, chromosome 11 makes up around 4% of human genomic DNA and is considered a gene and Molecular Weight of FOXRED1 isoform 1: 54 kDa. -
Low Abundance of the Matrix Arm of Complex I in Mitochondria Predicts Longevity in Mice
ARTICLE Received 24 Jan 2014 | Accepted 9 Apr 2014 | Published 12 May 2014 DOI: 10.1038/ncomms4837 OPEN Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice Satomi Miwa1, Howsun Jow2, Karen Baty3, Amy Johnson1, Rafal Czapiewski1, Gabriele Saretzki1, Achim Treumann3 & Thomas von Zglinicki1 Mitochondrial function is an important determinant of the ageing process; however, the mitochondrial properties that enable longevity are not well understood. Here we show that optimal assembly of mitochondrial complex I predicts longevity in mice. Using an unbiased high-coverage high-confidence approach, we demonstrate that electron transport chain proteins, especially the matrix arm subunits of complex I, are decreased in young long-living mice, which is associated with improved complex I assembly, higher complex I-linked state 3 oxygen consumption rates and decreased superoxide production, whereas the opposite is seen in old mice. Disruption of complex I assembly reduces oxidative metabolism with concomitant increase in mitochondrial superoxide production. This is rescued by knockdown of the mitochondrial chaperone, prohibitin. Disrupted complex I assembly causes premature senescence in primary cells. We propose that lower abundance of free catalytic complex I components supports complex I assembly, efficacy of substrate utilization and minimal ROS production, enabling enhanced longevity. 1 Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. 2 Centre for Integrated Systems Biology of Ageing and Nutrition, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. 3 Newcastle University Protein and Proteome Analysis, Devonshire Building, Devonshire Terrace, Newcastle upon Tyne NE1 7RU, UK. Correspondence and requests for materials should be addressed to T.v.Z. -
COX6B1 Antibody - N-Terminal Region Rabbit Polyclonal Antibody Catalog # AI15391
10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 COX6B1 Antibody - N-terminal region Rabbit Polyclonal Antibody Catalog # AI15391 Specification COX6B1 Antibody - N-terminal region - Product Information Application WB Primary Accession P14854 Other Accession NM_001863, NP_001854 Reactivity Human, Mouse, Rat, Rabbit, Pig, Horse, Yeast, Bovine, Guinea Pig, Dog Predicted Human, Mouse, Host: Rabbit Rat, Rabbit, Pig, Target Name: COX6B1 Horse, Yeast, Sample Tissue: OVCAR-3 Whole cell lysate Bovine, Guinea Pig, Dog s Host Rabbit Antibody Dilution: 1.0μg/ml Clonality Polyclonal Calculated MW 10kDa KDa COX6B1 Antibody - N-terminal region - References COX6B1 Antibody - N-terminal region - Additional Information Taanman J.-W.,et al.Nucleic Acids Res. 17:1766-1766(1989). Gene ID 1340 Taanman J.-W.,et al.Gene 93:285-291(1990). Carrero-Valenzuela R.D.,et al.Gene Alias Symbol COX6B, COXG, 102:229-236(1991). COXVIb1 Ota T.,et al.Nat. Genet. 36:40-45(2004). Other Names Kalnine N.,et al.Submitted (MAY-2003) to the Cytochrome c oxidase subunit 6B1, EMBL/GenBank/DDBJ databases. Cytochrome c oxidase subunit VIb isoform 1, COX VIb-1, COX6B1, COX6B Format Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. Reconstitution & Storage Add 50 ul of distilled water. Final anti-COX6B1 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. Precautions COX6B1 Antibody - N-terminal region is for Page 1/3 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 research use only and not for use in diagnostic or therapeutic procedures.